Literature DB >> 2833601

Natural history of adenocarcinoma-large cell carcinoma of the lung: conclusions from screening programs in New York and Baltimore.

B J Flehinger1, M Kimmel, M R Melamed.   

Abstract

A mathematical model of the progression kinetics of lung cancer was described and used to shed light on the natural history of adenocarcinoma and large cell carcinoma of lung from data collected in screening studies of male smokers by the Memorial Sloan-Kettering Cancer Center and The Johns Hopkins Medical Institutions. In both programs, estimates of the mean duration of early-stage adenocarcinoma or large cell carcinoma of lung ranged upward from 4 years, and estimates of the probability of detecting it in early-stage disease ranged downward from .16. The probabilities of curing early-stage disease through surgical treatment were found to be at most .52 and .13 in the New York and Baltimore studies, respectively. These estimates led to the conclusion that expected reduction in mortality from adenocarcinoma and large cell carcinoma of lung as due to annual x-ray screening from age 45 to 80 years is not greater than 18% in New York and 5% in Baltimore.

Entities:  

Mesh:

Year:  1988        PMID: 2833601     DOI: 10.1093/jnci/80.5.337

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  5 in total

Review 1.  Calibration methods used in cancer simulation models and suggested reporting guidelines.

Authors:  Natasha K Stout; Amy B Knudsen; Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  Comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model.

Authors:  Ray S Lin; Sylvia K Plevritis
Journal:  Cancer Causes Control       Date:  2011-11-25       Impact factor: 2.506

3.  Primary care radiography in the early diagnosis of lung cancer.

Authors:  Trevor K Rogers
Journal:  Cancer Imaging       Date:  2010-03-16       Impact factor: 3.909

4.  Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study.

Authors:  V Paul Doria-Rose; Pamela M Marcus; Eva Szabo; Melvyn S Tockman; Myron R Melamed; Philip C Prorok
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

5.  Evaluation of cancer prevention strategies by computerized simulation model: an approach to lung cancer.

Authors:  N Yamaguchi; Y Tamura; T Sobue; S Akiba; M Ohtaki; Y Baba; S Mizuno; S Watanabe
Journal:  Cancer Causes Control       Date:  1991-05       Impact factor: 2.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.